Continuous SGLT2 inhibitor versus DPP4 inhibitor use was also associated with lower risks of both AD and VD, strengthening previous evidence [13]
Beyond its direct fat-reducing effects, AOD9604 enhances the bodys overall metabolic efficiency
The speed of weight loss depends on several factors: your starting weight, metabolism, diet quality, physical activity level, and how quickly your dose escalates
6 Care should also be taken with alogliptin
The FDA also required changes to the labels to achieve a more uniform presentation of side effects and risk information for all of the drugs in the GLP-1 category, including adding or changing subsections for Acute Pancreatitis and Severe Gastrointestinal Adverse Reactions and revising the Patient Counseling section and Medication Guide. Some of the labels were also updated with post-marketing reports of hair loss (alopecia) and the neurological symptom of altered sense of touch, or dysethesia
Pharmacological Treatment of Obesity: A Review (2011)